ArticleCureus2025

Trends in Glucagon-Like Peptide-1 Agonist Use and BMI Among Obese Adults With Type 2 Diabetes: Analysis of the 2010-2015 National Ambulatory Medical Care Survey (NAMCS), Adjusted for Cardiovascular Comorbidity.

Victoria Eneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.